Latest Insider Transactions at Geron Corp (GERN)
This section provides a real-time view of insider transactions for Geron Corp (GERN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GERON CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GERON CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Robert J. Spiegel |
SELL
Grant, award, or other acquisition
|
Direct |
1,767
-1.03%
|
-
|
|
Jul 08
2024
|
Andrew J Grethlein EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
674,348
-100.0%
|
$2,697,392
$4.56 P/Share
|
|
Jul 08
2024
|
Andrew J Grethlein EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
674,348
+50.0%
|
$674,348
$1.72 P/Share
|
|
Jun 28
2024
|
Robert J. Spiegel |
SELL
Grant, award, or other acquisition
|
Direct |
1,916
-1.12%
|
-
|
|
Jun 10
2024
|
Anil Kapur EVP, Corp Strategy & CCO |
SELL
Open market or private sale
|
Direct |
421,875
-100.0%
|
$1,687,500
$4.64 P/Share
|
|
Jun 10
2024
|
Anil Kapur EVP, Corp Strategy & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
421,875
+50.0%
|
$421,875
$1.06 P/Share
|
|
Jun 10
2024
|
Faye Feller EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
287,900
-100.0%
|
$1,151,600
$4.63 P/Share
|
|
Jun 10
2024
|
Faye Feller EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
287,900
+50.0%
|
$287,900
$1.14 P/Share
|
|
Jun 04
2024
|
John A Scarlett Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-50.0%
|
$2,400,000
$4.0 P/Share
|
|
Jun 04
2024
|
John A Scarlett Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
600,000
+50.0%
|
$1,200,000
$2.54 P/Share
|
|
May 15
2024
|
V Bryan Lawlis |
SELL
Open market or private sale
|
Direct |
35,000
-100.0%
|
$105,000
$3.75 P/Share
|
|
May 15
2024
|
V Bryan Lawlis |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
$35,000
$1.94 P/Share
|
|
Mar 29
2024
|
Robert J. Spiegel |
SELL
Grant, award, or other acquisition
|
Direct |
2,462
-1.46%
|
-
|
|
Dec 29
2023
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
3,406
+2.03%
|
-
|
|
Dec 29
2023
|
Gaurav Aggarwal |
BUY
Grant, award, or other acquisition
|
Direct |
1,970
+50.0%
|
-
|
|
Dec 29
2023
|
Susan Molineaux |
BUY
Grant, award, or other acquisition
|
Indirect |
6,220
+4.55%
|
-
|
|
Sep 29
2023
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
3,390
+2.07%
|
-
|
|
Sep 29
2023
|
Susan Molineaux |
BUY
Grant, award, or other acquisition
|
Indirect |
6,191
+4.74%
|
-
|
|
Aug 24
2023
|
Elizabeth G. O'Farrell |
BUY
Open market or private purchase
|
Indirect |
6,579
+20.06%
|
$13,158
$2.28 P/Share
|
|
Aug 24
2023
|
Elizabeth G. O'Farrell |
BUY
Open market or private purchase
|
Direct |
6,607
+47.15%
|
$13,214
$2.28 P/Share
|
|
Jun 30
2023
|
Susan Molineaux |
BUY
Grant, award, or other acquisition
|
Indirect |
4,088
+3.35%
|
-
|
|
Jun 30
2023
|
Anil Kapur EVP, Corp Strategy & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
7,567
+11.07%
|
$15,134
$2.04 P/Share
|
|
Jun 30
2023
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
2,239
+1.4%
|
-
|
|
May 11
2023
|
V Bryan Lawlis |
SELL
Open market or private sale
|
Direct |
35,000
-100.0%
|
$105,000
$3.0 P/Share
|
|
May 11
2023
|
V Bryan Lawlis |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
$35,000
$1.1 P/Share
|
|
May 01
2023
|
Susan Molineaux |
SELL
Open market or private sale
|
Direct |
35,000
-100.0%
|
$70,000
$2.48 P/Share
|
|
May 01
2023
|
Susan Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
$35,000
$1.1 P/Share
|
|
Mar 31
2023
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
3,312
+2.09%
|
-
|
|
Mar 31
2023
|
Susan Molineaux |
BUY
Grant, award, or other acquisition
|
Indirect |
6,048
+5.04%
|
-
|
|
Feb 10
2023
|
John A Scarlett Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
446,668
-100.0%
|
$1,340,004
$3.0 P/Share
|
|
Feb 10
2023
|
John A Scarlett Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
446,668
+50.0%
|
$446,668
$1.5 P/Share
|
|
Feb 09
2023
|
John A Scarlett Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
446,666
-100.0%
|
$1,339,998
$3.03 P/Share
|
|
Feb 09
2023
|
John A Scarlett Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
446,666
+50.0%
|
$446,666
$1.5 P/Share
|
|
Feb 09
2023
|
Andrew J Grethlein EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
384,719
-69.49%
|
$1,154,157
$3.03 P/Share
|
|
Feb 09
2023
|
Andrew J Grethlein EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+28.05%
|
$150,000
$1.51 P/Share
|
|
Feb 08
2023
|
John A Scarlett Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
446,666
-100.0%
|
$1,339,998
$3.08 P/Share
|
|
Feb 08
2023
|
John A Scarlett Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
446,666
+50.0%
|
$446,666
$1.5 P/Share
|
|
Feb 08
2023
|
Olivia Kyusuk Bloom EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
400,000
-84.28%
|
$1,200,000
$3.08 P/Share
|
|
Feb 08
2023
|
Olivia Kyusuk Bloom EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+45.74%
|
$400,000
$1.51 P/Share
|
|
Jan 13
2023
|
Karin Eastham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+24.3%
|
$35,000
$1.1 P/Share
|
|
Dec 30
2022
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
2,970
+1.92%
|
-
|
|
Dec 30
2022
|
Anil Kapur EVP, Corp Strategy & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
6,021
+10.16%
|
$6,021
$1.11 P/Share
|
|
Sep 30
2022
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
3,071
+2.02%
|
-
|
|
Sep 12
2022
|
Andrew J Grethlein EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
234,719
+49.89%
|
$234,719
$1.7 P/Share
|
|
Jun 30
2022
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
4,637
+3.09%
|
-
|
|
Jun 30
2022
|
Anil Kapur EVP, Corp Strategy & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
13,062
+21.68%
|
$13,062
$1.11 P/Share
|
|
Apr 20
2022
|
Karin Eastham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+32.1%
|
$35,000
$1.41 P/Share
|
|
Mar 31
2022
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
5,284
+3.61%
|
-
|
|
Dec 31
2021
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
5,891
+4.16%
|
-
|
|
Sep 30
2021
|
Robert J. Spiegel |
BUY
Grant, award, or other acquisition
|
Direct |
5,246
+3.88%
|
-
|